Abstract
A number of antibodies have been identified in some cancer sera. Some of these react with tissue constituents and others with certain cellular components. One of these—a newly described antibody believed to react with an antigen closely related to cytoplasmic microtubules—is capable of cross reacting widely with many different fixed cells, making the identification of tumour specific antibodies more complex. Despite the presence of this antibody in the sera of some patients with malignant melanoma, a preliminary study suggests that there exists in the sera of many of these patients an antibody with a greater affinity for the cytoplasm of melanoma cells than that of a non-malignant cell. The possible significance of these various antibodies is discussed.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Doniach D., Walker J. G. A unified concept of autoimmune hepatitis. Lancet. 1969 Apr 19;1(7599):813–815. doi: 10.1016/s0140-6736(69)92072-8. [DOI] [PubMed] [Google Scholar]
- Farrow L. J., Holborow E. J., Brighton W. D. Reaction of human smooth muscle antibody with liver cells. Nat New Biol. 1971 Aug 11;232(2):186–187. doi: 10.1038/newbio232186a0. [DOI] [PubMed] [Google Scholar]
- Farrow L. J., Holborow E. J., Johnson G. D., Lamb S. G., Stewart J. S., Taylor P. E., Zuckerman A. J. Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J. 1970 Jun 20;2(5711):693–695. doi: 10.1136/bmj.2.5711.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hellström I., Sjögren H. O., Warner G., Hellström K. E. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer. 1971 Mar 15;7(2):226–237. doi: 10.1002/ijc.2910070206. [DOI] [PubMed] [Google Scholar]
- Lewis M. G., Ikonopisov R. L., Nairn R. C., Phillips T. M., Fairley G. H., Bodenham D. C., Alexander P. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J. 1969 Sep 6;3(5670):547–552. doi: 10.1136/bmj.3.5670.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morton D. L., Malmgren R. A., Holmes E. C., Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968 Jul;64(1):233–240. [PubMed] [Google Scholar]
- Muna N. M., Marcus S., Smart C. Detection by immunofluorescence of antibodies specific for human malignant melanoma cells. Cancer. 1969 Jan;23(1):88–93. doi: 10.1002/1097-0142(196901)23:1<88::aid-cncr2820230109>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- Oettgen H. F., Aoki T., Old L. J., Boyse E. A., de Harven E., Mills G. M. Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J Natl Cancer Inst. 1968 Oct;41(4):827–843. [PubMed] [Google Scholar]
- Romsdahl M. M., Cox I. S. Human malignant melanoma antibodies demonstrated by immunofluorescence. Arch Surg. 1970 Apr;100(4):491–497. doi: 10.1001/archsurg.1970.01340220167028. [DOI] [PubMed] [Google Scholar]
- Whitehouse J. M., Holborow E. J. Smooth muscle antibody in malignant disease. Br Med J. 1971 Nov 27;4(5786):511–513. doi: 10.1136/bmj.4.5786.511. [DOI] [PMC free article] [PubMed] [Google Scholar]